Table of TCGA Cancer Codes · 2019-06-29 · Table of TCGA Cancer Codes ! TCGA code Cancer type...
56
Table of TCGA Cancer Codes TCGA code Cancer type Number* ACC Adrenocortical carcinoma 90 BLCA Bladder urothelial carcinoma 396 BRCA Breast invasive carcinoma 988 CESC Cervical squamous cell carcinoma and endocervical adenocarcinoma 194 CHOL Cholangiocarcinoma (bile duct) 35 COAD Colon adenocarcinoma 367 DLBC Lymphoid neoplasm diffuse large B−cell lymphoma 48 ESCA Esophageal carcinoma 185 GBM Glioblastoma multiforme 290 HNSC Head and neck squamous cell carcinoma 513 KICH Kidney chromophobe 66 KIRC Kidney renal clear cell carcinoma 451 KIRP Kidney renal papillary cell carcinoma 282 LAML Acute myeloid leukemia 197 LGG Brain lower grade glioma 533 LIHC Liver hepatocellular carcinoma 373 LUAD Lung adenocarcinoma 546 LUSC Lung squamous cell carcinoma 178 OV Ovarian serous cystadenocarcinoma 469 PAAD Pancreatic adenocarcinoma 185 PCPG Pheochromocytoma and paraganglioma (adrenal gland) 184 PRAD Prostate adenocarcinoma 499 READ Rectum adenocarcinoma 122 SARC Sarcoma 247 SKCM Skin cutaneous melanoma 371 STAD Stomach adenocarcinoma 395 TGCT Testicular germ cell tumors 155 THCA Thyroid carcinoma 504 THYM Thymoma 123 UCEC Uterine corpus endometrial carcinoma 248 UCS Uterine carcinosarcoma 57 UVM Uveal melanoma 8 *Number of samples with mutation data
Transcript of Table of TCGA Cancer Codes · 2019-06-29 · Table of TCGA Cancer Codes ! TCGA code Cancer type...
Table of TCGA Cancer Codes TCGA code
Cancer type Number*
ACC Adrenocortical carcinoma 90 BLCA Bladder urothelial carcinoma 396 BRCA Breast invasive carcinoma 988 CESC Cervical squamous cell carcinoma and endocervical
adenocarcinoma 194
CHOL Cholangiocarcinoma (bile duct) 35 COAD Colon adenocarcinoma 367 DLBC Lymphoid neoplasm diffuse large B−cell lymphoma 48 ESCA Esophageal carcinoma 185 GBM Glioblastoma multiforme 290 HNSC Head and neck squamous cell carcinoma 513 KICH Kidney chromophobe 66 KIRC Kidney renal clear cell carcinoma 451 KIRP Kidney renal papillary cell carcinoma 282 LAML Acute myeloid leukemia 197 LGG Brain lower grade glioma 533 LIHC Liver hepatocellular carcinoma 373 LUAD Lung adenocarcinoma 546 LUSC Lung squamous cell carcinoma 178 OV Ovarian serous cystadenocarcinoma 469 PAAD Pancreatic adenocarcinoma 185 PCPG Pheochromocytoma and paraganglioma (adrenal gland) 184 PRAD Prostate adenocarcinoma 499 READ Rectum adenocarcinoma 122 SARC Sarcoma 247 SKCM Skin cutaneous melanoma 371 STAD Stomach adenocarcinoma 395 TGCT Testicular germ cell tumors 155 THCA Thyroid carcinoma 504 THYM Thymoma 123 UCEC Uterine corpus endometrial carcinoma 248 UCS Uterine carcinosarcoma 57 UVM Uveal melanoma 8 *Number of samples with mutation data
V12
1F
E10
79K
E71
1K
F35
9L
T38
4S
R83
6H
Q39
0R
EGFR mutant alleles in bladder urothelial carcinoma (N=396)0.
00.
20.
40.
60.
81.
0
NbrSamples=396 Mutant Samples=7 Total Mutations=7
V12
1
E10
79
E71
1
F35
9
T38
4
R83
6
Q39
0
EGFR mutant positions in bladder urothelial carcinoma (N=396)0.
00.
20.
40.
60.
81.
0
NbrSamples=396 Mutant Samples=7 Total Mutations=7
D31
4G
D10
51N
T27
3A
E11
4K
EGFR mutant alleles in breast invasive carcinoma (N=988)0.
00.
51.
01.
52.
0
NbrSamples=988 Mutant Samples=5 Total Mutations=5
D31
4
D10
51
T27
3
E11
4
EGFR mutant positions in breast invasive carcinoma (N=988)0.
00.
51.
01.
52.
0
NbrSamples=988 Mutant Samples=5 Total Mutations=5
I789
M
S81
1C
V10
97I
W73
1*
V55
0L
EGFR mutant alleles in cervical squamous cell carcinoma and endocervical adenocarcinoma (N=194)0.
00.
20.
40.
60.
81.
0
NbrSamples=194 Mutant Samples=4 Total Mutations=5
I789
S81
1
V10
97
W73
1
V55
0
EGFR mutant positions in cervical squamous cell carcinoma and endocervical adenocarcinoma (N=194)0.
00.
20.
40.
60.
81.
0
NbrSamples=194 Mutant Samples=4 Total Mutations=5
L730
FP
699H
D91
6VY
801C
L62P
S92
1RQ
1164
*T
790M
K74
5RT
725A
N70
0DE
697G
K74
5ME
746G
V74
2IL7
47*
L707
*G
721C
P59
6LE
734D
V80
2AL7
07S
C21
9RK
708R
G72
4S
EGFR mutant alleles in colon adenocarcinoma (N=367), top 250.
00.
51.
01.
52.
02.
53.
0
NbrSamples=367 Mutant Samples=75 Total Mutations=105(72 not shown)
T79
0T
725
N70
0E
697
E74
6L7
47S
768
P73
3G
721
R22
2P
596
E73
4G
63V
802
S78
4C
219
V74
2S
921
L814
K70
8K
745
E88
4Q
1164
G72
4L7
07
EGFR mutant positions in colon adenocarcinoma (N=367), top 250.
00.
51.
01.
52.
02.
53.
0
NbrSamples=367 Mutant Samples=75 Total Mutations=105 (57 not shown)
W51
6L
R57
4W
P37
3S
L113
9F
G59
8E
EGFR mutant alleles in esophageal carcinoma (N=185)0.
00.
20.
40.
60.
81.
0
NbrSamples=185 Mutant Samples=5 Total Mutations=5
W51
6
R57
4
P37
3
L113
9
G59
8
EGFR mutant positions in esophageal carcinoma (N=185)0.
00.
20.
40.
60.
81.
0
NbrSamples=185 Mutant Samples=5 Total Mutations=5
F25
4ID
807H
G63
K76
8_76
9ins
VD
SC
223Y
C62
8FK
714N
R10
8GY
270C
C62
0WC
571S
C24
0YP
596L
P59
6SG
598A
L62R
E70
9KR
252C
A28
9DH
304Y
R22
2CR
108K
A28
9TG
598V
A28
9V
EGFR mutant alleles in glioblastoma multiforme (N=290), top 250
24
68
1012
NbrSamples=290 Mutant Samples=77 Total Mutations=95(27 not shown)
R42
7S
229
T36
3C
636
T26
3F
254
D80
776
8_76
9ins
VD
SC
223
K71
4Y
270
C57
1C
240
C62
0L6
2E
709
C62
8G
63H
304
R25
2R
222
P59
6R
108
G59
8A
289
EGFR mutant positions in glioblastoma multiforme (N=290), top 250
510
1520
NbrSamples=290 Mutant Samples=77 Total Mutations=95 (15 not shown)
P54
6Q
D19
1N
E45
Q
G50
3S
A41
9P
I475
V
F78
L
P37
3Q
L38V
GAT
CV
288f
s
S22
9C
A28
9T
F71
2L
S22
0P
E96
7A
G58
8S
R99
9H
E87
2G
S88
5*
EGFR mutant alleles in head and neck squamous cell carcinoma (N=513)0.
00.
20.
40.
60.
81.
0
NbrSamples=513 Mutant Samples=19 Total Mutations=19
P54
6
D19
1
E45
G50
3
A41
9
I475
F78
P37
3
L38
GAT
CV
288
S22
9
A28
9
F71
2
S22
0
E96
7
G58
8
R99
9
E87
2
S88
5
EGFR mutant positions in head and neck squamous cell carcinoma (N=513)0.
00.
20.
40.
60.
81.
0
NbrSamples=513 Mutant Samples=19 Total Mutations=19
E33
0K
S10
42N
H80
5R
R83
2H
L838
P
CP
264f
s
L838
M
EGFR mutant alleles in kidney renal clear cell carcinoma (N=451)0.
00.
51.
01.
52.
0
NbrSamples=451 Mutant Samples=9 Total Mutations=9
E33
0
S10
42
H80
5
R83
2
CP
264
L838
EGFR mutant positions in kidney renal clear cell carcinoma (N=451)0.
00.
51.
01.
52.
02.
53.
0
NbrSamples=451 Mutant Samples=9 Total Mutations=9
D25
6GE
84V
E31
7KD
321Y
Q27
6LG
665D
F40
4fs
G31
2WQ
1143
*V
774M
T26
3IW
880*
G72
4ST
263P
E70
9KG
719D
R32
4LY
891C
A58
3SR
252P
R10
8KR
252C
L62R
G59
8VA
289V
EGFR mutant alleles in brain lower grade glioma (N=533), top 250
12
34
56
7
NbrSamples=533 Mutant Samples=36 Total Mutations=46(4 not shown)
A61
3D
837
D25
6E
84E
317
D32
1Q
276
G66
5F
404
G31
2Q
1143
V77
4W
880
G72
4E
709
G71
9R
324
Y89
1A
583
T26
3R
108
L62
R25
2G
598
A28
9
EGFR mutant positions in brain lower grade glioma (N=533), top 250
12
34
56
7
NbrSamples=533 Mutant Samples=36 Total Mutations=46 (2 not shown)
N77
1S
S22
7fs
P41
1R
I744
V
769_
770i
nsA
SV
EGFR mutant alleles in liver hepatocellular carcinoma (N=373)0.
00.
51.
01.
52.
0
NbrSamples=373 Mutant Samples=6 Total Mutations=6
N77
1
S22
7
P41
1
I744
769_
770i
nsA
SV
EGFR mutant positions in liver hepatocellular carcinoma (N=373)0.
00.
51.
01.
52.
0
NbrSamples=373 Mutant Samples=6 Total Mutations=6
773_
774i
nsH
E86
6KLR
EAT
747d
elV
300M
K75
4EQ
486*
L387
MD
1084
fsG
901V
Q43
2HK
754I
L907
MS
921R
I91V
R10
52I
G62
7*L6
2RL2
10L
G71
9AL8
61Q
S76
8I70
9_71
0ET
>D
ELR
746d
elE
LRE
A74
6del
L858
R
EGFR mutant alleles in lung adenocarcinoma (N=546), top 250
510
1520
NbrSamples=546 Mutant Samples=73 Total Mutations=87(14 not shown)
773_
774i
nsH
E86
6LR
EAT
747d
elV
300
Q48
6L3
87D
1084
G90
1Q
432
L907
S92
1I9
1R
1052
G62
7L8
33 L62
L210
K75
4L8
61S
768
G71
970
9_71
0ET
>D
ELR
746d
elE
LRE
A74
6del
L858
EGFR mutant positions in lung adenocarcinoma (N=546), top 250
510
1520
NbrSamples=546 Mutant Samples=73 Total Mutations=87 (11 not shown)
P10
19L
P58
9L
S72
0C
V84
3L
L861
Q
EGFR mutant alleles in lung squamous cell carcinoma (N=178)0.
00.
51.
01.
52.
0
NbrSamples=178 Mutant Samples=6 Total Mutations=6
P10
19
P58
9
S72
0
V84
3
L861
EGFR mutant positions in lung squamous cell carcinoma (N=178)0.
00.
51.
01.
52.
0
NbrSamples=178 Mutant Samples=6 Total Mutations=6
A83
9V
E70
9Q
P77
2R
S38
0fs
Q11
64R
K26
1N
EGFR mutant alleles in ovarian serous cystadenocarcinoma (N=469)0.
00.
20.
40.
60.
81.
0
NbrSamples=469 Mutant Samples=6 Total Mutations=6
A83
9
E70
9
P77
2
S38
0
Q11
64
K26
1
EGFR mutant positions in ovarian serous cystadenocarcinoma (N=469)0.
00.
20.
40.
60.
81.
0
NbrSamples=469 Mutant Samples=6 Total Mutations=6
D10
12G
K70
8E
E11
4K
N70
0D
G72
1S
Y76
4H
P75
3L
N75
6S
Y81
3C
G63
R
L703
P
EGFR mutant alleles in rectum adenocarcinoma (N=122)0.
00.
20.
40.
60.
81.
0
NbrSamples=122 Mutant Samples=9 Total Mutations=11
D10
12
K70
8
E11
4
N70
0
G72
1
Y76
4
P75
3
N75
6
Y81
3
G63
L703
EGFR mutant positions in rectum adenocarcinoma (N=122)0.
00.
20.
40.
60.
81.
0
NbrSamples=122 Mutant Samples=9 Total Mutations=11
D10
09N
C26
4YP
100S
S11
6FP
622S
P51
2SQ
390K
R57
4RE
319K
T59
4IL7
82F
G91
7RE
400K
M65
0IP
699L
L541
FD
303N
R95
8CP
934S
S36
4FP
753S
H47
YE
922K
N23
4SQ
982*
EGFR mutant alleles in skin cutaneous melanoma (N=371), top 250.
00.
51.
01.
52.
0
NbrSamples=371 Mutant Samples=24 Total Mutations=34(8 not shown)
D10
09C
264
P10
0S
116
P62
2P
512
Q39
0R
574
E31
9T
594
L782
G91
7E
400
M65
0P
699
L541
D30
3R
958
P93
4S
364
P75
3H
47E
922
N23
4Q
982
EGFR mutant positions in skin cutaneous melanoma (N=371), top 250.
00.
51.
01.
52.
0
NbrSamples=371 Mutant Samples=24 Total Mutations=34 (8 not shown)
A92
0S
D76
1N
V32
3I
G50
3C
P93
7L
R10
68*
T63
8M
T43
0I
I351
V
D24
7N
R53
1*
V85
M
R10
31Q
C26
4fs
R32
4H
G23
9S
P64
4L
R25
2H
EGFR mutant alleles in stomach adenocarcinoma (N=395)0.
00.
51.
01.
52.
0
NbrSamples=395 Mutant Samples=19 Total Mutations=19
A92
0
D76
1
V32
3
G50
3
P93
7
R10
68
T63
8
T43
0
I351
D24
7
R53
1
V85
R10
31
C26
4
R32
4
G23
9
P64
4
R25
2
EGFR mutant positions in stomach adenocarcinoma (N=395)0.
00.
51.
01.
52.
0
NbrSamples=395 Mutant Samples=19 Total Mutations=19
Y82
7*
V44
1I
V14
8M
L541
I
S19
8R
L116
7M
S43
7Y
R83
2C
P69
4S
L140
V
G91
7A
V74
2I
EGFR mutant alleles in uterine corpus endometrial carcinoma (N=248)0.
00.
20.
40.
60.
81.
0
NbrSamples=248 Mutant Samples=8 Total Mutations=12
Y82
7
V44
1
V14
8
L541
S19
8
L116
7
S43
7
R83
2
P69
4
L140
G91
7
V74
2
EGFR mutant positions in uterine corpus endometrial carcinoma (N=248)0.
00.
20.
40.
60.
81.
0
NbrSamples=248 Mutant Samples=8 Total Mutations=12
P11
78L
P58
9L
P59
6L
P75
3S
Q11
64R
R10
8G
R10
8K
R22
2C
R25
2C
R25
2P
R37
7K
S22
9C
S92
1R
T26
3P
T63
8M
T79
0M
V10
97I
V15
9M
V74
2I
V77
4M
V84
3L
E11
4K
G63
R
G71
9D
L62R
Number of cancer types where each EGFR mutation occurs, top 250.
00.
51.
01.
52.
02.
53.
0
320 not shown
S72
0
S76
8
S92
1
T63
8
T79
0
V10
97
V15
9
V74
2
V84
3
W73
1
A28
9
D25
6
E11
4
G63
G72
1
P75
3
R10
8
R37
7
T26
3
V77
4
E70
9
G59
8
G71
9
L62
R25
2
Number of cancer types where each EGFR mutation position occurs, top 250
12
34
271 not shown
P11
78L
Q98
2*
R25
2H
G63
R
G71
9D
A28
9D
H30
4Y
E70
9K
R25
2P
S76
8I
709_
710E
T>
D
ELR
746d
el
E11
4K
P59
6L
G72
4S
R22
2C
R25
2C
L861
Q
R10
8K
A28
9T
L62R
ELR
EA
746d
el
G59
8V
A28
9V
L858
R
Number of times each EGFR mutation occurs across all cancer types, top 250
510
1520
342 not shown
S92
1
K70
8
H30
4
L838
709_
710E
T>
D
ELR
746d
el
E11
4
G72
1
T26
3
Q11
64
G72
4
S76
8
G63
E70
9
L861
R22
2
G71
9
P59
6
R10
8
L62
R25
2
ELR
EA
746d
el
G59
8
L858
A28
9
Number of times each EGFR mutation position occurs across all cancer types, top 250
510
1520
2530
302 not shown
HN
SC
LGG
GB
M
Total number of EGFR A289 mutations in different cancer types0
510
1520
HN
SC
LGG
GB
M
Mutated allele breakdown for EGFR A289 mutations0
510
1520
A289DA289VA289TA289NA289I
HN
SC
LGG
GB
M All
Proportional view of allele breakdown of EGFR A289 mutations0.
00.
20.
40.
60.
81.
0 1 7 23 31
A289DA289VA289TA289NA289I
LUA
D
05
1015
20Total number of EGFR L858 mutations in different cancer types
LUA
D
05
1015
20
L858R
Mutated allele breakdown for EGFR L858 mutations
LUA
D All
0.0
0.2
0.4
0.6
0.8
1.0 22 22
L858R
Proportional view of allele breakdown of EGFR L858 mutations
CO
AD
ES
CA
LGG
GB
M
Total number of EGFR G598 mutations in different cancer types0
24
68
1012
14
CO
AD
ES
CA
LGG
GB
M
Mutated allele breakdown for EGFR G598 mutations0
24
68
1012
14
G598*G598EG598VG598A
CO
AD
ES
CA
LGG
GB
M All
Proportional view of allele breakdown of EGFR G598 mutations0.
00.
20.
40.
60.
81.
0 1 1 6 14 22
G598*G598EG598VG598A
LUA
D
05
1015
Total number of EGFR ELREA746del mutations in different cancer types
LUA
D
05
1015
ELREA746del
Mutated allele breakdown for EGFR ELREA746del mutations
LUA
D All
0.0
0.2
0.4
0.6
0.8
1.0 17 17
ELREA746del
Proportional view of allele breakdown of EGFR ELREA746del mutations
CO
AD
STA
D
GB
M
LGG
Total number of EGFR R252 mutations in different cancer types0
12
34
5
CO
AD
STA
D
GB
M
LGG
Mutated allele breakdown for EGFR R252 mutations0
12
34
5
R252SR252CR252PR252H
CO
AD
STA
D
GB
M
LGG All
Proportional view of allele breakdown of EGFR R252 mutations0.
00.
20.
40.
60.
81.
0 1 2 3 5 11
R252SR252CR252PR252H
ES
CA
HN
SC
CO
AD
STA
D
LGG
LUA
D
GB
M
010
2030
40
A289G598L858ELREA746delR252
Positional breakdown of EGFR mutations across cancer types
ES
CA
HN
SC
CO
AD
STA
D
LGG
LUA
D
GB
M All
0.0
0.2
0.4
0.6
0.8
1.0 1 1 2 2 18 39 40 10
3
A289G598L858ELREA746delR252
Proportional position breakdown of EGFR mutations
![· Web viewIn the Cancer Genome Atlas (TCGA) project, the somatic cancer variants were annotated in four different layers, including tumor types, genes, variants, and drugs [23]](https://static.fdocuments.in/doc/165x107/5ea7ba4a9e40290ae43e482f/web-view-in-the-cancer-genome-atlas-tcga-project-the-somatic-cancer-variants.jpg)
